Sujata Rao博士被任命为英矽智能首席医学官 (IMAGE)

InSilico Medicine

Sujata Rao博士被任命为英矽智能首席医学官

Caption

在任期内，她带领英矽智能全球临床团队成功将公司领先的特发性肺纤维化（IPF）候选药物INS018_055推进到2期临床试验阶段，这也是全球首款由AI发现和设计的候选药物，现已完成首批患者给药。

Credit

英矽智能

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.